BioProcess Insider - News BioProcess International

GSK confident traditional vaccine tech has major role in COVID-19 efforts

The headline-makers in the race to develop a COVID-19 vaccine are not the traditional firms, but GSK says its proven adjuvant approach will set its offering apart. During GlaxoSmithKline’s (GSK’s) second quarter financial call, an analyst from Wolfe Research pointed out the vanguard of COVID- ...

Merck betting on ‘swish-and-swallow’ and single administration COVID vaccines
A recombinant vesicular stomatitis virus-based COVID-19 vaccine may be active when administered orally, says Merck as it begins clinical manufact ...
Base editing firm Beam licenses Oxford Biomedica’s vector tech
Beam Therapeutics has licensed use of Oxford Biomedica’s Lentivector platform for the development of CAR-T therapies. Under the deal Beam ca ...
ABC news: Lonza to scale-up ophthalmic therapy for Kodiak
CDMO Lonza will use its global network, including a dedicated facility in Switzerland, to produce Kodiak Sciences’ antibody biopolymer conjugat ...
Pfizer blasts Trump’s pricing plans, threatens to pull US investments
CEO Albert Bourla says Pfizer will rethink plans to invest in US R&D and manufacturing after lambasting four executive orders aimed at reduci ...

Covering the whole development process for the global biotechnology industry

More From BioProcess Insider

Recent Tweets

Recent Tweets

Trending